| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,231 |
2,611 |
$195K |
| 96136 |
|
620 |
536 |
$17K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
113 |
108 |
$14K |
| 94729 |
|
281 |
272 |
$14K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
102 |
102 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
472 |
414 |
$11K |
| 94727 |
|
281 |
272 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
1,654 |
1,464 |
$7K |
| 94010 |
|
281 |
272 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
80 |
74 |
$6K |
| 90674 |
|
244 |
215 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
279 |
271 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
204 |
182 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14 |
14 |
$2K |
| 36410 |
|
116 |
63 |
$189.20 |
| 93000 |
|
15 |
14 |
$180.96 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
291 |
282 |
$161.91 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$40.72 |
| 90661 |
|
14 |
12 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
84 |
57 |
$0.00 |
| 99000 |
|
796 |
650 |
$0.00 |